scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Annarita Falanga | Q42849600 |
Mco Guida | Q42862110 | ||
Giovanni Libralato | Q51682833 | ||
Lucia Lombardi | Q57320966 | ||
Emilia Galdiero | Q88341567 | ||
Rosa Carotenuto | Q91801391 | ||
P2860 | cites work | Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor | Q24569680 |
Marine Antimicrobial Peptides: Nature Provides Templates for the Design of Novel Compounds against Pathogenic Bacteria | Q26746943 | ||
A new zebrafish model of oro-intestinal pathogen colonization reveals a key role for adhesion in protection by probiotic bacteria | Q27343098 | ||
Innate immunity and the normal microflora | Q28373296 | ||
Broad-spectrum anti-biofilm peptide that targets a cellular stress response | Q28539079 | ||
Genome evolution in the allotetraploid frog Xenopus laevis | Q30275672 | ||
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. | Q30424697 | ||
In vivo imaging and genetic analysis link bacterial motility and symbiosis in the zebrafish gut. | Q30479332 | ||
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity | Q33876601 | ||
LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents | Q34058299 | ||
Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide | Q34165875 | ||
Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics. | Q39447286 | ||
Streptococcus-zebrafish model of bacterial pathogenesis | Q39655603 | ||
Microbiological diagnosis of biofilm-related infections. | Q40192726 | ||
Cyclic di-AMP mediates biofilm formation | Q40969149 | ||
Mechanisms of biofilm inhibition and degradation by antimicrobial peptides | Q41242922 | ||
Experimental models of bone and prosthetic joint infections | Q41683193 | ||
Structural insights into and activity analysis of the antimicrobial peptide myxinidin. | Q42209245 | ||
Zebrafish embryo screen for mycobacterial genes involved in the initiation of granuloma formation reveals a newly identified ESX-1 component | Q42775615 | ||
Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria | Q44484590 | ||
Helix induction in antimicrobial peptides by alginate in biofilms | Q44973236 | ||
The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents. | Q46242249 | ||
Purification, characterization and application of a novel antimicrobial peptide from Andrias davidianus blood | Q46262933 | ||
Alginate as an auxiliary bacterial membrane: binding of membrane-active peptides by polysaccharides | Q46401626 | ||
Antibiofilm activity of carboxymethyl chitosan on the biofilms of non-Candida albicans Candida species | Q46537638 | ||
Pathogenic Elizabethkingia miricola Infection in Cultured Black-Spotted Frogs, China, 2016. | Q47116277 | ||
Binary Colloidal Crystal Layers as Platforms for Surface Patterning of Puroindoline-Based Antimicrobial Peptides. | Q47215716 | ||
Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus. | Q47297726 | ||
Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis. | Q48137993 | ||
Do host-associated gut microbiota mediate the effect of an herbicide on disease risk in frogs? | Q48187466 | ||
The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems | Q50095135 | ||
Mechanisms of antimicrobial peptide action and resistance | Q34181099 | ||
Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation | Q34527130 | ||
Control of cell selectivity of antimicrobial peptides | Q34865746 | ||
Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria | Q35866086 | ||
A novel short anionic antibacterial peptide isolated from the skin of Xenopus laevis with broad antibacterial activity and inhibitory activity against breast cancer cell | Q35948561 | ||
Amphibian skin as a source of therapeutic peptides | Q36149238 | ||
The role of 'atypical' Brucella in amphibians: are we facing novel emerging pathogens? | Q36163561 | ||
Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool. | Q36176823 | ||
A Combined Molecular Cloning and Mass Spectrometric Method to Identify, Characterize, and Design Frenatin Peptides from the Skin Secretion of Litoria infrafrenata. | Q36177009 | ||
Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. | Q36213685 | ||
APD3: the antimicrobial peptide database as a tool for research and education | Q36434966 | ||
Temporins, anti-infective peptides with expanding properties | Q36435250 | ||
An integrated study on antimicrobial activity and ecotoxicity of quantum dots and quantum dots coated with the antimicrobial peptide indolicidin | Q37226531 | ||
Structure-activity relations of myxinidin, an antibacterial peptide derived from the epidermal mucus of hagfish | Q37263518 | ||
Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides | Q37385746 | ||
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents | Q37532896 | ||
Host-microbe interactions in the developing zebrafish | Q37691890 | ||
The contribution of skin antimicrobial peptides to the system of innate immunity in anurans. | Q37773817 | ||
Use of antimicrobial peptides against microbial biofilms: advantages and limits | Q37812624 | ||
Structural diversity and species distribution of host-defense peptides in frog skin secretions | Q37874199 | ||
Antimicrobial peptides: key components of the innate immune system | Q37954721 | ||
β-Defensins: multifunctional modulators of infection, inflammation and more? | Q37996291 | ||
The chemistry and biological activities of peptides from amphibian skin secretions | Q38320713 | ||
Antimicrobial peptides as an opportunity against bacterial diseases | Q38373510 | ||
Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria | Q38622715 | ||
Promising Approaches to Optimize the Biological Properties of the Antimicrobial Peptide Esculentin-1a(1-21)NH2: Amino Acids Substitution and Conjugation to Nanoparticles | Q38685826 | ||
Discovery of Phylloseptins that Defense against Gram-Positive Bacteria and Inhibit the Proliferation of the Non-Small Cell Lung Cancer Cell Line, from the Skin Secretions of Phyllomedusa Frogs | Q38693901 | ||
New frontiers for anti-biofilm drug development | Q38741798 | ||
Antimicrobial peptides at work: interaction of myxinidin and its mutant WMR with lipid bilayers mimicking the P. aeruginosa and E. coli membranes. | Q38745454 | ||
Antibiofilm Peptides: Potential as Broad-Spectrum Agents | Q38805599 | ||
Eradication of Staphylococcus aureus Biofilm Infections Using Synthetic Antimicrobial Peptides. | Q38814378 | ||
Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a(1-21)NH2 as a reliable strategy for antipseudomonal drugs. | Q38815672 | ||
Anti-biofilm peptides as a new weapon in antimicrobial warfare. | Q38869269 | ||
Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines | Q39203205 | ||
Antibiofilm peptides against biofilms on titanium and hydroxyapatite surfaces. | Q55527564 | ||
Potent effects of amino acid scanned antimicrobial peptide Feleucin-K3 analogs against both multidrug-resistant strains and biofilms of Pseudomonas aeruginosa | Q57133670 | ||
Microbial-derived products as potential new antimicrobials | Q57865591 | ||
Ethical considerations in the use of animal models in infection | Q58675396 | ||
Tuberculosis caused by Mycobacterium bovis infection in a captive-bred American bullfrog (Lithobates catesbeiana) | Q58706388 | ||
Action of Antimicrobial Peptides against Bacterial Biofilms | Q60916150 | ||
Frog Skin Innate Immune Defences: Sensing and Surviving Pathogens | Q61448766 | ||
Enhancing the Potency of Antimicrobial Peptides through Molecular Engineering and Self-Assembly | Q62470824 | ||
Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of spp. clinical isolates | Q62470827 | ||
Polymicrobial antibiofilm activity of the membranotropic peptide gH625 and its analogue | Q62512843 | ||
Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents | Q80459060 | ||
Antimicrobial coatings prepared from Dhvar-5-click-grafted chitosan powders | Q90353494 | ||
Antibiofilm elastin-like polypeptide coatings: functionality, stability, and selectivity | Q90433353 | ||
Application of tungsten disulfide quantum dot-conjugated antimicrobial peptides in bio-imaging and antimicrobial therapy | Q91112990 | ||
Regulation of virulence and antibiotic resistance in Gram-positive microbes in response to cell wall-active antibiotics | Q91508207 | ||
A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model | Q91892444 | ||
A New Hope: Self-Assembling Peptides with Antimicrobial Activity | Q93105355 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P921 | main subject | biofilm | Q467410 |
antimicrobial peptide | Q1201508 | ||
P577 | publication date | 2019-07-10 | |
P1433 | published in | Pharmaceutics | Q27723332 |
P1476 | title | Biofilms: Novel Strategies Based on Antimicrobial Peptides | |
P478 | volume | 11 |